Hai-Bo Wei

Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.

F. Liu, Hai-Bo Wei, Xiang-shi Lu, 2011, Archives of medical research.

Rapamycin synergizes with low-dose oxaliplatin in the HCT116 colon cancer cell line by inducing enhanced apoptosis.

Hai-Bo Wei, Wenxin Zheng, Xiaojin Zhang, 2011, Oncology letters.

A meta-analytic review of ERCC1/MDR1 polymorphism and chemosensitivity to platinum in patients with advanced non-small cell lung cancer.

Hai-Bo Wei, Li-hua Shang, Jing Hu, 2012, Chinese medical journal.